A powerful wave of medical innovation is giving new hope to millions of cancer patients across the globe and it's being led by a specific class of targeted therapies that are rewriting the future of oncology. HER2 antibodies are not just transforming how we treat breast cancer—they’re creating a booming market with unprecedented growth potential and life saving outcomes. The Her2...